F2 and liver disorder: The MELD score is a prospectively developed and validated scale for the severity of end-stage liver disease that uses the quantitative, objective values of serum TBIL, serum creatinine, and INR of prothrombin time to predict patient mortality in patients with advanced liver disease [16,40].